OPT News and Press, Opthea Limited From 08/28/23

2023-08-28 06:57:48 ET More on Opthea Opthea receives $170M in non-dilutive financing for OPT-302 in wet AMD Opthea names seasoned pharmaceutical executive Dr. Joel Naor as CMO Seeking Alpha’s Quant Rating on Opthea For further details see: Opthea ...

OPT has successfully completed the placement and institutional entitlement offer components of its previously announced capital raising As a result of strong demand from both existing and new domestic and offshore institutional investors Opthea has accepted an additional A$10.0 million in ove...

(NewsDirect) Ocean Power Technologies vice president of sales Matt Burdyny joined Steve Darling from Proactive to share an exciting development within the company. Ocean Power Technologies has achieved a significant milestone by successfully demonstrating the capabilities of its Wave ...

MONROE TOWNSHIP, N.J., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT) , a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, is proud to announce a p...

MONROE TOWNSHIP, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Ocean Power Technologies, Inc. (NYSE American: OPTT), please note the headline has been corrected. Complete corrected text follows. Ocean Power Technologies to Report 2024 First Quarter ...

All amounts are stated in United States dollars unless otherwise indicated Revenue of $11.1 million Total Contract Value (“TCV”) 1 bookings of $20.0 million Gross margin of 65% Adjusted EBITDA 1 loss of $0.3 million Adjusted EPS 1 loss of ($0.21) ...

MONROE TOWNSHIP, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced that it will report its fiscal 2024 first quarter...

MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that the American Medical Association’s United Sta...

MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Chief Execut...

(NewsDirect) Ocean Power Technologies (OPT) CEO Philipp Stratmann joined Natalie Stoberman from the Proactive studios to discuss the company's growth strategy in the field of ocean intelligence. Stratmann said OPT has successfully pivoted into the ocean intelligence industry, offering...